Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1988 Aug;79(8):973–981. doi: 10.1111/j.1349-7006.1988.tb00063.x

Immunoscintigraphy and Pharmacokinetics of Indium‐111‐labeled ZME‐018 Monoclonal Antibody in Patients with Malignant Melanoma

Mitsuru Koizumi 1, Keigo Endo 1,✉, Yuji Watanabe 1, Tsuneo Saga 1, Harumi Sakahara 1, Junji Konishi 1, Yasusi Arano 3, Yoshiki Miyachi 2, Mari Kashihara‐Sawami 2, Sadao Imamura 2
PMCID: PMC5917606  PMID: 3141332

Abstract

Immunoscintigraphic and pharmacokinetic characteristics of 111In‐labeled ZME‐018 monoclonal antibody were examined in 8 patients with malignant melanoma. Each patient received a single intravenous infusion of 20 mg of ZME‐018, coupled to 3 mCi of 111In without any acute toxicity. Scintigrams were taken 1, 3, and 6 days after the administration, and blood and urine samples were also taken frequently. Rapid clearance of some radioactivity was seen in early urine samples in the form of 111In DTPA, but after 1 day, urinary excretion of radioactivity was slow and steady, with an average of 2.5% of the injected dose excreted per day. The scans demonstrated that there was blood retention of radioactivity in the heart and great vessels 1 day after infusion and considerable clearance from the blood pool occurred by 3 days. However, 111In was deposited in the liver, spleen and bone for up to 6 days. The optimal time for imaging appeared to be at 3 days. Nineteen out of 26 known lesions or 6 out of 8 patients were positive. There were 21 lesions detected that were not suspected during the work‐up the patient. Five patients developed human anti‐mouse antibody in the serum by 3 weeks. These results suggest that immunoscintigraphy with 111In‐labeled ZME‐018 antibody is safe and useful for the detection of metastatic lesions in a selected group of patients with malignant melanoma.

Keywords: Monoclonal antibody, ZME‐018; Malignant melanoma; Immunoscintigraphy; Indium‐111

Full Text

The Full Text of this article is available as a PDF (639.6 KB).

References

  • 1).Larson , S. M. , Brown , J. P. , Wright , P. W. , Carrasquillo , J. A. , Hellström , I. and Hellström , K. E.Imaging of melanoma with I‐131‐labeled monoclonal antibodies . J. Nucl. Med. , 24 , 123 – 129 ( 1983. ). [PubMed] [Google Scholar]
  • 2).Delaloye , B. , Bischof‐Delaloye , A. , Buchegger , F. , Von Fliedner , V. , Grob , J. P. , Volant , J. C. , Pettelval , J. and Mach , J. P.Detection of colorectal carcinoma by emission‐computed tomography after injection of 123I‐labeled Fab or F(ab')2 fragments from monoclonal anti‐carcinoembryonic antigen antibodies . J. Clin. Invest. , 77 , 301 – 311 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3).Carrasquillo , J. A. , Bunn , P. A. , Keenan , A. M. , Reynolds , J. C. , Schroff , R. W. , Foon , K. A. , Ming‐Hsu , S. , Gazdav , A. F. , Mulshine , J. L. , Oldham , R. K. , Petentesis , P. , Horowitz , M. , Eddy , J.James , P. and Larson , S. M.Radioimmunodetection of cutaneous T‐cell lymphoma with 111In‐labeled T 101 monoclonal antibody . N. Engl. J. Med. , 315 , 673 – 680 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 4).Cerry , T. , Owens , S. E. , Mackenzie , S. A. , Nuttall , P. M. , Gosh , A. K. , Smith , D. B. and Thatcher , N.Immunoscintigraphy with 99mTc labelled F(ab')2 fragments of an antimelanoma monoclonal antibody (225, 28S) in patients with metastatic melanoma . Eur. J. Nucl. Med. , 13 , 130 – 133 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 5).Carrasquillo , J. A. , Krohn , K. A. , Beaumier , P. , McGuffin , R. W. , Brown , J. P. , Hellström , K. E. , Hellström , I. and Larson , S. M.Diagnosis and therapy for solid tumors with radiolabeled antibodies and immune fragments . Cancer Treat. Rep. , 68 , 317 – 328 ( 1984. ). [PubMed] [Google Scholar]
  • 6).Murray , J. L. , Rosenblum , M. G. , Sobol , R. E. , Bartholomew , R. M. , Plager , C. E. , Haynie , T. P. , Glenn J. II. , Lamki , L. , Benjamin , R. S. , Papadopoulos , N. , Boddie , A. W. , Frincke , J. M. , David , G. S. , Carlo , D. and Hersh , E. M.Radioimmunoimaging in malignant melanoma with 111In‐labeled monoclonal antibody 96.5 . Cancer Res. , 45 , 2376 – 2381 ( 1985. ). [PubMed] [Google Scholar]
  • 7).Halpern , S. E. , Dillman , R. O. , Witztum , K. F. , Shega , J. F. , Hagan , P. L. , Burrows , W. M. , Dillman , J. B. , Clutter , M. L. , Sobol , R. E. , Frinke , J. M. , Bartholomew , R. M. , David , G. S. and Carlo , D. J.Radioimmunodetection of melanoma utilizing In‐111 96.5 monoclonal antibody: a preliminary report . Radiology , 155 , 493 – 499 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 8).Murray , J. L. , Rosenblum , M. G. , Lamki , L. , Glenn , H. J. , Krizan , Z. , Hersh , E. M. , Plegan , C. E. , Bartholomew , R. M. , Unger , M. W. and Carlo , D. J.Clinical parameters related to optimal tumor localization of indium ‐111 ‐ labeled mouse antimelanoma monoclonal antibody ZME‐018 . J. Nucl. Med. , 28 , 25 – 33 ( 1987. ). [PubMed] [Google Scholar]
  • 9).Wilson , B. S. , Imai , K. , Natali , P. G. and Ferrone , S.Distribution and molecular characterization of a cell‐surface and a cytoplasmic antigen detectable in human melanoma cell with monoclonal antibodies . Int. J. Cancer , 28 , 293 – 300 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 10).Natali , P. G. , Cavaliere , R. , Bigotti , A. , Nicotra , M. R. , Russo , C. , Giacomini , P. and Ferrone , S.Antigenic heterogeneity of surgically removed primary and autologous metastatic human melanoma lesions . J. Immunol. , 130 , 1462 – 1466 ( 1983. ). [PubMed] [Google Scholar]
  • 11).Giacomini , P. , Natali , P. G. and Ferrone , S.Analysis of interaction between a human melanoma high‐molecular‐weight melanoma‐associated antigen and monoclonal antibodies to three distinct antigenic determinants . J. Immunol. , 135 , 696 – 702 ( 1985. ). [PubMed] [Google Scholar]
  • 12).Giacomini , P. , Velgia , F. , Cordiali , P. , Rehle , T. , Natali , P. G. and Ferrone , S.Level of a melanoma membrane‐bound high‐molecular‐weight melanoma‐associated antigen and a cytoplasmic melanoma‐associated antigen in surgically removed tissues and in sera from patients with melanoma . Cancer Res. , 44 , 1281 – 1287 ( 1984. ). [PubMed] [Google Scholar]
  • 13).Krejecarek , G. E. and Tucker , K. L.Covalent attachment of chelation groups to macromolecules . Biochem. Biophys. Res. Commun. , 77 , 581 – 585 ( 1977. ). [DOI] [PubMed] [Google Scholar]
  • 14).Hnatwich , D. J. , Gionet , M. , Rusckowski , M. , Siebecker , D. A. , Roche , J. , Shealy , D. , Mattis , J. A. , Wilson , J. , McGann , J. , Hunter , R. E. , Griffin , T. , and Doherty , J.Pharmacokinetics of 111In‐labeled OC‐125 antibody in cancer patients compared with the 19‐9 antibody , Cancer Res. , 47 , 6111 – 6117 ( 1987. ). [PubMed] [Google Scholar]
  • 15).Shawler , D. L. , Bartholomew , R. M. , Smith , L. M. and Dillman , R. O.Human immune response to multiple injections of murine Ig G . J. Immunol. , 135 , 1530 – 1535 ( 1985. ). [PubMed] [Google Scholar]
  • 16).Saha , G. B. and Boyd , C. M.A two‐compartment analysis of plasma clearance and urinary excretion data of 111In‐DTPA in dog . Int. J. Nucl. Med. Biol. , 9 , 122 – 125 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 17).Kashihara , M. , Ueda , M. , Horiguchi , Y. , Furukawa , F. , Hanaoka , M. and Imamura , S.A monoclonal antibody specifically reactive to human Langerhans cells . J. Invest. Dermatol. , 87 , 602 – 607 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 18).Sakahara , H. , Endo , K. , Nakashima , T. , Koizumi , M. , Kunimatsu , M. , Kawamura , Y. , Ohta , H. , Nakamura , T. , Tanaka , H. , Kotoura , Y. , Yamamoto , T. , Hosoi , S. , Toyama , S. and Torizuka , T.Localization of human osteogenic sarcoma xenografts in nude mice by a monoclonal antibody labeled with radioiodine and indium‐111 . J. Nucl. Med. , 28 , 342 – 348 ( 1987. ). [PubMed] [Google Scholar]
  • 19).Datz , F. L. “ Gamuts in Nuclear Medicine ” pp . 184 – 187 ( 1983. ). Appleton‐Century‐Ctofts; , Connecticut . [Google Scholar]
  • 20).Vecchio , S. D. , Reynolds , J. C. , Carrosquillo , J. A. , Lova , M. E. and Larson , S. M.Human anti‐mouse antibody (HAMA) concentration and human‐murine antibody (antibody‐antibody) complexes . J. Nucl. Med. , 28 , 614 – 615 ( 1987. ). [Google Scholar]
  • 21).Brown , B. A. , Davis , G. L. , Muller , J. S. , Simon , P. , Ho , M. K. , Shaw , P. S. , Stone , B. A. , Sanda , H. and Moore , G. P.Tumor‐specific genetically engineered murine/human chimeric monoclonal antibody . Cancer Res. , 47 , 3577 – 3583 ( 1987. ). [PubMed] [Google Scholar]
  • 22).Nishimura , Y. , Yokoyama , M. , Arai , K. , Ueda , R. , Kudo , A. and Watanabe , T.Recombinant human‐mouse chimeric monoclonal antibody specific for common acute lymphocytic leukemia antigen . Cancer Res. , 47 , 999 – 1005 ( 1987. ). [PubMed] [Google Scholar]
  • 23).Kusama , M. , Kageshita , T. , Tsujisaki , M. , Perosa , F. and Ferrone , S.Syngenic anti‐idiotypic antisera to murine antihuman high‐molecular‐weight melanoma‐associated antigen monoclonal antibody . Cancer Res. , 47 , 4312 – 4317 ( 1987. ). [PubMed] [Google Scholar]
  • 24).Dillman , D. O. , Shawler , D. L. , Dillman , J. B. and Royston , I.Therapy of chronic lymphocytic leukemia and cutaneous T‐cell lymphoma with T 101 monoclonal antibody . J. Clin. Oncol. , 2 , 881 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 25).Hnatwich , D. J. , Virizi , F. and Doherty , P. W.DTPA‐coupled antibodies labeled with yttrium . J. Nucl. Med. , 26 , 503 – 509 ( 1985. ). [PubMed] [Google Scholar]
  • 26).Koizumi , M. , Endo , K. , Kunimatsu , M. , Sakahara , H. , Nakashima , T. , Kawamura , Y. , Watanabe , Y. , Saga , T. , Konishi , J. , Hosoi , S. , Toyama , S. , Arano , Y. and Yokoyama , A.Gallium‐67 labeled antibodies for immunoscintigraphy and evaluation of tumor targeting of drug‐antibody conjugates . Cancer Res. , 48 , 1189 – 1194 ( 1988. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES